Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inhibikase Therapeutics, Inc. | Director | Common Stock | 1.46M | $2M | $1.37 | Oct 21, 2024 | Indirect |
Inhibikase Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 108K | Jun 30, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IKT | Inhibikase Therapeutics, Inc. | Jun 30, 2025 | 1 | $0 | 4 | Jul 2, 2025 | Director |
IKT | Inhibikase Therapeutics, Inc. | Feb 14, 2025 | 2 | $0 | 4 | Feb 19, 2025 | Director |
IKT | Inhibikase Therapeutics, Inc. | Oct 21, 2024 | 2 | $2M | 4 | Oct 23, 2024 | Director |
IKT | Inhibikase Therapeutics, Inc. | Oct 21, 2024 | 0 | $0 | 3 | Oct 23, 2024 | Director |